journal
https://read.qxmd.com/read/38656341/publisher-correction-epithelial-recognition-and-elimination-against-aberrant-cells
#1
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
No abstract text is available yet for this article.
April 24, 2024: Seminars in Immunopathology
https://read.qxmd.com/read/38647672/correction-glycoprotein-2-as-a-gut-gate-keeper-for-mucosal-equilibrium-between-inflammation-and-immunity
#2
Zhongwei Zhang, Izumi Tanaka, Rika Nakahashi-Ouchida, Peter B Ernst, Hiroshi Kiyono, Yosuke Kurashima
No abstract text is available yet for this article.
April 22, 2024: Seminars in Immunopathology
https://read.qxmd.com/read/38451292/physiological-and-immunological-barriers-in-the-lung
#3
REVIEW
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, Hiroshi Nakajima
The lungs serve as the primary organ for respiration, facilitating the vital exchange of gases with the bloodstream. Given their perpetual exposure to external particulates and pathogens, they possess intricate protective barriers. Cellular adhesion in the lungs is robustly maintained through tight junctions, adherens junctions, and desmosomes. Furthermore, the pulmonary system features a mucociliary clearance mechanism that synthesizes mucus and transports it to the outside. This mucus is enriched with chemical barriers like antimicrobial proteins and immunoglobulin A (IgA)...
March 7, 2024: Seminars in Immunopathology
https://read.qxmd.com/read/38411739/epithelial-recognition-and-elimination-against-aberrant-cells
#4
REVIEW
Shiyu Ayukawa, Nagisa Kamoshita, Takeshi Maruyama
Epithelial cells, which are non-immune cells, not only function as a physical defence barrier but also continuously monitor and eliminate aberrant epithelial cells in their vicinity. In other words, it has become evident that epithelial cells possess immune cell-like functions. In fact, recent research has revealed that epithelial cells recognise the Major Histocompatibility Complex I (MHC-I) of aberrant cells as a mechanism for surveillance. This cellular defence mechanism of epithelial cells probably detects aberrant cells more promptly than the conventional immune response, making it a novel and primary biological defence...
February 27, 2024: Seminars in Immunopathology
https://read.qxmd.com/read/38305897/disease-pathogenesis-and-barrier-functions-regulated-by-group-3-innate-lymphoid-cells
#5
REVIEW
Ayana Mori, Hiroshi Ohno, Naoko Satoh-Takayama
The mucosal surface is in constant contact with foreign antigens and is regulated by unique mechanisms that are different from immune responses in the peripheral organs. For the last several decades, only adaptive immune cells such as helper T (Th) cells, Th1, Th2, or Th17 were targeted to study a wide variety of immune responses in the mucosal tissues. However, since their discovery, innate lymphoid cells (ILCs) have been attracting attention as a unique subset of immune cells that provide border defense with various functions and tissue specificity...
February 2, 2024: Seminars in Immunopathology
https://read.qxmd.com/read/38170255/glycoprotein-2-as-a-gut-gate-keeper-for-mucosal-equilibrium-between-inflammation-and-immunity
#6
REVIEW
Zhongwei Zhang, Izumi Tanaka, Rika Nakahashi-Ouchida, Peter B Ernst, Hiroshi Kiyono, Yosuke Kurashima
Glycoprotein 2 (GP2) is a widely distributed protein in the digestive tract, contributing to mucosal barrier maintenance, immune homeostasis, and antigen-specific immune response, while also being linked to inflammatory bowel disease (IBD) pathogenesis. This review sheds light on the extensive distribution of GP2 within the gastrointestinal tract and its intricate interplay with the immune system. Furthermore, the significance of GP2 autoantibodies in diagnosing and categorizing IBD is underscored, alongside the promising therapeutic avenues for modulating GP2 to regulate immunity and maintain mucosal balance...
January 3, 2024: Seminars in Immunopathology
https://read.qxmd.com/read/38078911/the-overlooked-bacterial-pandemic
#7
REVIEW
Danilo Gomes Moriel, Diego Piccioli, Maria Michelina Raso, Mariagrazia Pizza
The COVID-19 pandemic had a significant economic and health impact worldwide. It also reinforced the misperception that only viruses can pose a threat to human existence, overlooking that bacteria (e.g., plague and cholera) have severely haunted and shaped the course of human civilization. While the world is preparing for the next viral pandemic, it is again overlooking a silent one: antimicrobial resistance (AMR). This review proposes to show the impact of bacterial infections on civilization to remind the pandemic potential...
December 11, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37870569/causes-and-costs-of-global-covid-19-vaccine-inequity
#8
REVIEW
Maddalena Ferranna
Despite the rapid development of safe and effective COVID-19 vaccines and the widely recognized health and economic benefits of vaccination, there exist stark differences in vaccination rates across country income groups. While more than 70% of the population is fully vaccinated in high-income countries, vaccination rates in low-income countries are only around 30%. The paper reviews the factors behind global COVID-19 vaccine inequity and the health, social, and economic costs triggered by this inequity. The main contributors to vaccine inequity include vaccine nationalism, intellectual property rights, constraints in manufacturing capacity, poor resilience of healthcare systems, and vaccine hesitancy...
October 23, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37436465/the-role-of-vaccines-in-the-covid-19-pandemic-what-have-we-learned
#9
REVIEW
Florian Krammer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged late in 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic that has so far claimed approximately 20 million lives. Vaccines were developed quickly, became available in the end of 2020, and had a tremendous impact on protection from SARS-CoV-2 mortality but with emerging variants the impact on morbidity was diminished. Here I review what we learned from COVID-19 from a vaccinologist's perspective.
July 12, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37273022/thromboinflammatory-challenges-in-stroke-pathophysiology
#10
REVIEW
R D Szepanowski, S Haupeltshofer, S E Vonhof, B Frank, C Kleinschnitz, A I Casas
Despite years of encouraging translational research, ischemic stroke still remains as one of the highest unmet medical needs nowadays, causing a tremendous burden to health care systems worldwide. Following an ischemic insult, a complex signaling pathway emerges leading to highly interconnected thrombotic as well as neuroinflammatory signatures, the so-called thromboinflammatory cascade. Here, we thoroughly review the cell-specific and time-dependent role of different immune cell types, i.e., neutrophils, macrophages, T and B cells, as key thromboinflammatory mediators modulating the neuroinflammatory response upon stroke...
June 5, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37138042/immune-compartments-at-the-brain-s-borders-in-health-and-neurovascular-diseases
#11
REVIEW
Jennifer E Goertz, Lidia Garcia-Bonilla, Costantino Iadecola, Josef Anrather
Recent evidence implicates cranial border immune compartments in the meninges, choroid plexus, circumventricular organs, and skull bone marrow in several neuroinflammatory and neoplastic diseases. Their pathogenic importance has also been described for cardiovascular diseases such as hypertension and stroke. In this review, we will examine the cellular composition of these cranial border immune niches, the potential pathways through which they might interact, and the evidence linking them to cardiovascular disease...
May 3, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37335353/unveiling-the-immunopathology-of-stroke-a-comprehensive-view-on-brain-immune-interaction
#12
EDITORIAL
Tim Magnus, Arthur Liesz
No abstract text is available yet for this article.
May 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37212886/the-role-of-circulating-cell-free-dna-as-an-inflammatory-mediator-after-stroke
#13
REVIEW
Stefan Roth, Saskia R Wernsdorf, Arthur Liesz
Stroke is the second leading cause of death worldwide and a leading cause of disability. Clinical and experimental studies highlighted the complex role of the immune system in the pathophysiology of stroke. Ischemic brain injury leads to the release of cell-free DNA, a damage-associated molecular pattern, which binds to pattern recognition receptors on immune cells such as toll-like receptors and cytosolic inflammasome sensors. The downstream signaling cascade then induces a rapid inflammatory response. In this review, we are highlighting the characteristics of cell-free DNA and how these can affect a local as well as a systemic response after stroke...
May 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37052711/role-of-glia-and-extracellular-matrix-in-controlling-neuroplasticity-in-the-central-nervous-system
#14
REVIEW
Egor Dzyubenko, Dirk M Hermann
Neuronal plasticity is critical for the maintenance and modulation of brain activity. Emerging evidence indicates that glial cells actively shape neuroplasticity, allowing for highly flexible regulation of synaptic transmission, neuronal excitability, and network synchronization. Astrocytes regulate synaptogenesis, stabilize synaptic connectivity, and preserve the balance between excitation and inhibition in neuronal networks. Microglia, the brain-resident immune cells, continuously monitor and sculpt synapses, allowing for the remodeling of brain circuits...
May 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37045990/differences-in-the-post-stroke-innate-immune-response-between-young-and-old
#15
REVIEW
Mattia Gallizioli, Maria Arbaizar-Rovirosa, David Brea, Anna M Planas
Aging is associated to progressive changes impairing fundamental cellular and tissue functions, and the relationships amongst them through the vascular and immune systems. Aging factors are key to understanding the pathophysiology of stroke since they increase its risk and worsen its functional outcome. Most currently recognised hallmarks of aging are also involved in the cerebral responses to stroke. Notably, age-associated chronic low-grade inflammation is related to innate immune responses highlighted by induction of type-I interferon...
April 12, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/36917241/the-role-of-the-atp-adenosine-axis-in-ischemic-stroke
#16
REVIEW
Ines Sophie Schädlich, Riekje Winzer, Joschi Stabernack, Eva Tolosa, Tim Magnus, Björn Rissiek
In ischemic stroke, the primary neuronal injury caused by the disruption of energy supply is further exacerbated by secondary sterile inflammation. The inflammatory cascade is largely initiated by the purine adenosine triphosphate (ATP) which is extensively released to the interstitial space during brain ischemia and functions as an extracellular danger signaling molecule. By engaging P2 receptors, extracellular ATP activates microglia leading to cytokine and chemokine production and subsequent immune cell recruitment from the periphery which further amplifies post-stroke inflammation...
March 14, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37083948/novel-immunotherapeutic-combinations-moving-forward-the-modulation-of-the-immunosuppressive-microenvironment
#17
EDITORIAL
Mads Hald Andersen
No abstract text is available yet for this article.
March 2023: Seminars in Immunopathology
https://read.qxmd.com/read/37002376/the-role-of-macrophages-in-the-tumor-microenvironment-and-tumor-metabolism
#18
REVIEW
Pritam Sadhukhan, Tanguy Y Seiwert
The complexity and plasticity of the tumor microenvironment (TME) make it difficult to fully understand the intratumoral regulation of different cell types and their activities. Macrophages play a crucial role in the signaling dynamics of the TME. Among the different subtypes of macrophages, tumor-associated macrophages (TAMs) are often associated with poor prognosis, although some subtypes of TAMs can at the same time improve treatment responsiveness and lead to favorable clinical outcomes. TAMs are key regulators of cancer cell proliferation, metastasis, angiogenesis, extracellular matrix remodeling, tumor metabolism, and importantly immunosuppression in the TME by modulating various chemokines, cytokines, and growth factors...
March 2023: Seminars in Immunopathology
https://read.qxmd.com/read/36790488/towards-multiomic-analysis-of-oral-mucosal-pathologies
#19
REVIEW
Jakob Einhaus, Xiaoyuan Han, Dorien Feyaerts, John Sunwoo, Brice Gaudilliere, Somayeh H Ahmad, Nima Aghaeepour, Karl Bruckman, David Ojcius, Christian M Schürch, Dyani K Gaudilliere
Oral mucosal pathologies comprise an array of diseases with worldwide prevalence and medical relevance. Affecting a confined space with crucial physiological and social functions, oral pathologies can be mutilating and drastically reduce quality of life. Despite their relevance, treatment for these diseases is often far from curative and remains vastly understudied. While multiple factors are involved in the pathogenesis of oral mucosal pathologies, the host's immune system plays a major role in the development, maintenance, and resolution of these diseases...
February 15, 2023: Seminars in Immunopathology
https://read.qxmd.com/read/36786929/neuroimaging-is-the-new-spatial-omic-multi-omic-approaches-to-neuro-inflammation-and-immuno-thrombosis-in-acute-ischemic-stroke
#20
REVIEW
Benjamin Maïer, Amy S Tsai, Jakob F Einhaus, Jean-Philippe Desilles, Benoît Ho-Tin-Noé, Benjamin Gory, Marina Sirota, Richard Leigh, Robin Lemmens, Gregory Albers, Jean-Marc Olivot, Mikael Mazighi, Brice Gaudillière
Ischemic stroke (IS) is the leading cause of acquired disability and the second leading cause of dementia and mortality. Current treatments for IS are primarily focused on revascularization of the occluded artery. However, only 10% of patients are eligible for revascularization and 50% of revascularized patients remain disabled at 3 months. Accumulating evidence highlight the prognostic significance of the neuro- and thrombo-inflammatory response after IS. However, several randomized trials of promising immunosuppressive or immunomodulatory drugs failed to show positive results...
February 14, 2023: Seminars in Immunopathology
journal
journal
41663
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.